JWS
Juncture Wealth Strategies’s Neurocrine Biosciences NBIX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $501K | Sell |
3,987
-2,766
| -41% | -$348K | 0.18% | 71 |
|
|
2025
Q1 | $747K | Sell |
6,753
-529
| -7% | -$58.5K | 0.29% | 61 |
|
|
2024
Q4 | $994K | Sell |
7,282
-1,116
| -13% | -$152K | 0.37% | 42 |
|
|
2024
Q3 | $968K | Sell |
8,398
-200
| -2% | -$23K | 0.37% | 42 |
|
|
2024
Q2 | $1.18M | Buy |
8,598
+173
| +2% | +$23.8K | 0.5% | 35 |
|
|
2024
Q1 | $1.16M | Buy |
8,425
+343
| +4% | +$47.3K | 0.5% | 37 |
|
|
2023
Q4 | $1.06M | Buy |
+8,082
| New | +$1.06M | 0.48% | 38 |
|